The antitumor mechanism of EVO against RCC cells with increased JNK/PERK-mediated phosphorylation of the Bcl-2 protein leading to disruption of the MMP was demonstrated herein (Fig 8). The gene discussed is MAPK8; the disease is renal cell carcinoma.